[go: up one dir, main page]

DE60039441D1 - Tumormarker für frühes krebsstadium - Google Patents

Tumormarker für frühes krebsstadium

Info

Publication number
DE60039441D1
DE60039441D1 DE60039441T DE60039441T DE60039441D1 DE 60039441 D1 DE60039441 D1 DE 60039441D1 DE 60039441 T DE60039441 T DE 60039441T DE 60039441 T DE60039441 T DE 60039441T DE 60039441 D1 DE60039441 D1 DE 60039441D1
Authority
DE
Germany
Prior art keywords
tumormarker
early cancer
stadium
cancer stadium
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60039441T
Other languages
English (en)
Inventor
Takashi Muramatsu
Kohji Okamoto
Shinya Ikematsu
Munehiro Oda
Hideshi Kumai
Sadatoshi Sakuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anagenics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60039441D1 publication Critical patent/DE60039441D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G01N33/5758
    • G01N33/575
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60039441T 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium Expired - Lifetime DE60039441D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP25667899 1999-09-10
JP34540499 1999-12-03
JP2000033168 2000-02-10
PCT/JP2000/006147 WO2001020333A1 (en) 1999-09-10 2000-09-08 Early cancer tumor marker

Publications (1)

Publication Number Publication Date
DE60039441D1 true DE60039441D1 (de) 2008-08-21

Family

ID=27334550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60039441T Expired - Lifetime DE60039441D1 (de) 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium

Country Status (9)

Country Link
US (1) US7090983B1 (de)
EP (1) EP1215500B1 (de)
KR (1) KR100768985B1 (de)
CN (1) CN1232826C (de)
AT (1) ATE400813T1 (de)
AU (1) AU780957B2 (de)
CA (1) CA2384579C (de)
DE (1) DE60039441D1 (de)
WO (1) WO2001020333A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004036221A2 (en) * 2002-10-18 2004-04-29 Wyeth Compositions and methods for diagnosing and treating autoimmune disease
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
WO2004092992A1 (ja) * 2003-04-15 2004-10-28 Cell Signals Inc. 健康情報の提供システムおよび健康情報の提供方法
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
WO2007081386A2 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use
KR100777088B1 (ko) 2006-04-04 2007-11-28 재단법인 한국원자력의학원 간암을 진단하기 위한 마커인 lcn2, midkine 및tfpi, 그를 포함하는 키트 및 상기 마커를 이용한 간암예측 방법
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2021113A2 (de) 2006-05-11 2009-02-11 Raindance Technologies, Inc. Mikrofluidische vorrichtungen
EP3536396B1 (de) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
JPWO2009025094A1 (ja) * 2007-08-20 2010-11-18 大野 典也 哺乳動物の癌の診断方法
CA2705486C (en) * 2007-11-19 2019-04-02 Celera Corporation Lung cancer markers and uses thereof
CA2716854A1 (en) * 2008-02-29 2009-09-03 National University Corporation Nagoya University Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP4047367A1 (de) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
JP2010139293A (ja) * 2008-12-10 2010-06-24 Medical Therapies Ltd 早期癌腫瘍マーカー
EP3415235B1 (de) 2009-03-23 2025-11-12 Bio-Rad Laboratories, Inc. Manipulation von mikrofluidiktröpfchen
US20120164667A1 (en) * 2009-06-10 2012-06-28 Masanori Hara Method for test on diabetic nephropathy
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ, インコーポレイテッド デジタル検体分析
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
MX355020B (es) 2010-07-09 2018-04-02 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
MX341517B (es) 2010-08-13 2016-08-24 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
EP2622103B2 (de) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Sandwichassays in tröpfchen
NZ589251A (en) * 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
EP3736281A1 (de) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US9556470B2 (en) 2011-06-02 2017-01-31 Raindance Technologies, Inc. Enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP3524693A1 (de) 2012-04-30 2019-08-14 Raindance Technologies, Inc. Digitale analytanalyse
US9946887B2 (en) 2012-06-04 2018-04-17 Nokia Technologies Oy Method and apparatus for determining privacy policy based on data and associated values
US9664682B2 (en) 2012-11-20 2017-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Assay to measure midkine or pleiotrophin level for diagnosing a growth
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
WO2014172288A2 (en) 2013-04-19 2014-10-23 Raindance Technologies, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3090063B1 (de) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Verfahren zur detektion von latentem retrovirus
CN106461678A (zh) * 2014-05-26 2017-02-22 奥林巴斯株式会社 胰腺癌判定方法
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
KR20220000082U (ko) 2020-07-01 2022-01-10 박세현 곽 휴지 형 그림책

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3842304B2 (ja) 1992-10-08 2006-11-08 喬 村松 癌の診断、治療薬
JP3418416B2 (ja) 1992-10-08 2003-06-23 喬 村松 核酸診断法
WO2000031541A2 (en) 1998-11-20 2000-06-02 Georgetown University Method of detecting neurofibromatosis type 1

Also Published As

Publication number Publication date
KR100768985B1 (ko) 2007-10-22
EP1215500B1 (de) 2008-07-09
KR20020043577A (ko) 2002-06-10
CA2384579A1 (en) 2001-03-22
AU6876000A (en) 2001-04-17
WO2001020333A1 (en) 2001-03-22
EP1215500A1 (de) 2002-06-19
CN1390304A (zh) 2003-01-08
AU780957B2 (en) 2005-04-28
ATE400813T1 (de) 2008-07-15
US7090983B1 (en) 2006-08-15
EP1215500A4 (de) 2004-12-08
CN1232826C (zh) 2005-12-21
CA2384579C (en) 2010-12-07

Similar Documents

Publication Publication Date Title
DE60039441D1 (de) Tumormarker für frühes krebsstadium
NO20034777D0 (no) Anordning for måling av blodglukosekonsentrasjoner
NO20011887D0 (no) Framgangsmåte for ikke-invasiv måling av blod-analytt, med bedret optisk grenseflate
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69206195D1 (de) Mikrosammelröhrchen für Blut.
NL300253I2 (nl) Contrastmiddel voor diagnostische beeldvorming metverlengde retentie in bloed.
DE60016467D1 (de) Ct-systeme zur klinischen überprüfung
SI1535068T1 (sl) Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih
DE69804761D1 (de) Dreibeinstativ, insbesondere für Photographie
DE60041623D1 (de) Körperstützsystem für Patienten
DE60112705T2 (de) Blutsammelsatz
DK0749582T3 (da) Fremgangsmåde til diagnosticering af præeklampsi
DE60239042D1 (de) Haptene, Immunogene, Antikörper und Konjugate für 2-oxo-3-hydroxy LSD
NO20051596L (no) Fremgangsmater for a verifisere fluidbevegelse.
FR2781143B1 (fr) Support expansible a meandres pour un conduit anatomique,en particulier, un vaisseau sanguin
DE69906202D1 (de) Evakuiertes Blutentnahmeröhrchen zur schneller Blutgerinnung
DE60020899D1 (de) Messeinrichtung zur Blutdruckmessung
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
DE60135918D1 (de) Gerät für prostatekrebsdiagnose
ATE360798T1 (de) Vorrichtung zur messung einer optischen weglängenveränderung
ATE429440T1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
AU2002366555A1 (en) Diagnostic for early stage alzheimer's disease
AU2003261976A1 (en) METHOD OF ASSAYING OXIDIZED LDL-Beta2-GLYCOPROTEIN I COMPLEXIN VIVO
DE59811990D1 (de) Nachweis von Harnblasenkarzinom in einer Urinprobe
NO20054142L (no) In vitro diagnostisk test for enterovirale infeksjoner

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MEDICAL THERAPIES LTD., SYDNEY, NEW SOUTH WALE, AU

8364 No opposition during term of opposition